Composition and method for treating or preventing skeletal muscle fibrosis
OwnerMark Pines, Arnon Naglerinventors
Life of this patent
Estimating the term…
Abstract
A compound in combination with a pharmaceutically acceptable carrier, the compound having a formula: wherein: R1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl, and lower alkoxy; R2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy; and R3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl; and n is either 1 or 2; and pharmaceutically acceptable salts thereof; for use in treatment of or prevention of skeletal muscle fibrosis and/or for inducing skeletal muscle regeneration.
Claims36
A pharmaceutical composition for treating and/or preventing skeletal muscle fibrosis in a subject in need thereof, the composition comprising a pharmaceutically effective amount of a compound in combination with a pharmaceutically acceptable carrier, the compound having a formula:
- wherein:
- n is either 1 or 2
- R1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl, and lower alkoxy;
- R2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy;
- and R3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl;
- and pharmaceutically acceptable salts thereof.
A pharmaceutical compositions for improving or inducing skeletal muscle regeneration in a subject in need thereof, the composition comprising a pharmaceutically effective amount of a compound in combination with a pharmaceutically acceptable carrier, the compound having a formula:
- wherein:
- n is either 1 or 2
- R1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl, and lower alkoxy;
- R2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy;
- and R3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl;
- and pharmaceutically acceptable salts thereof.
A method for reducing the progression of skeletal muscle fibrosis in a subject in need thereof, the method comprising administering a pharmaceutically effective amount of a compound in combination with a pharmaceutically acceptable carrier, the compound having a formula:
- wherein:
- n is either 1 or 2
- R1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl, and lower alkoxy;
- R2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy;
- and R3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl;
- and pharmaceutically acceptable salts thereof.
A method for improving or inducing skeletal muscle regeneration in a subject in need thereof, the method comprising administering a pharmaceutically effective amount of a compound in combination with a pharmaceutically acceptable carrier, the compound having a formula:
- wherein:
- n is either 1 or 2
- R1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl, and lower alkoxy;
- R2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy;
- and R3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl;
- and pharmaceutically acceptable salts thereof.
Use of a compound having a formula:
- wherein:
- n is either 1 or 2
- R1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl, and lower alkoxy;
- R2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy;
- and R3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl;
- and pharmaceutically acceptable salts thereof;
- in the manufacture of a medicament for reducing the progression of skeletal muscle fibrosis in a subject in need thereof.
Dependencies are inferred from the claim text.